A detailed history of Cwm, LLC transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 17 shares of LRMR stock, worth $100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 13 30.77%
Holding current value
$100
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$6.3 - $10.68 $25 - $42
4 Added 30.77%
17 $0
Q2 2024

Jul 09, 2024

BUY
$6.33 - $9.89 $75 - $118
12 Added 1200.0%
13 $0
Q1 2024

Apr 05, 2024

BUY
$4.2 - $13.28 $4 - $13
1 New
1 $0
Q3 2023

Oct 11, 2023

BUY
$3.08 - $4.49 $264 - $386
86 New
86 $0

Others Institutions Holding LRMR

About Larimar Therapeutics, Inc.


  • Ticker LRMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,269,200
  • Market Cap $256M
  • Description
  • Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...
More about LRMR
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.